Neoadjuvant immunotherapy improves outcomes in high-risk melanoma patients.

Published Date: 02 Mar 2023

High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Orca-T Approved to Prevent GVHD After Stem Cell Transplant for Blood Cancers

2.

In leukemia, allogeneic HCT is beneficial following primary induction failure.

3.

Geriatric Assessment, QoL Correlate With OS in Older Patients with Pancreatic Cancer

4.

Guideline on management of early-stage non-small cell lung cancer released

5.

New Standard for Newly Diagnosed Pediatric B-Cell Acute Lymphoblastic Leukemia


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot